Breast Biopsy Devices Market by Type (Needles, Tables, Assay kits, Liquid Biopsy), Procedure (CNB, FNAB, VAB, Surgical), Technique (Stereotactic, USG, MRI), Application (Screening, Treatment), End User (Hospitals, Clinic) & Region - Global Forecast to 2028
The global breast biopsy devices market is projected to reach USD 2.6 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 10.0% from 2023 to 2028. The market growth is propelled by various factors, including the growing prevalence of breast cancer, the increasing implementation of breast cancer screening programs, favorable reimbursement settings, heightened awareness of early breast cancer detection, and rising demand for minimally invasive and non-invasive procedures. These factors are key drivers of market expansion, presenting significant business opportunities in the industry.
“The biopsy needles sub-segment to hold the largest share of the market in 2023.”
Based on type, the breast biopsy devices market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other devices. The biopsy needles sub-segment held a major share of the market. The advantages offered by the substantial market dominance of this segment can be primarily attributed to the increasing occurrence of breast cancer and the rising rate of breast cancer diagnosis in emerging markets. Moreover, supportive government initiatives, such as the establishment of breast cancer screening programs and awareness campaigns, are anticipated to drive the adoption of breast biopsy procedures further.
“The therapy selection application segment is projected to register the highest growth during the forecast period.”
Based on application, the near breast biopsy market is broadly categorized into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The significant growth of the segment is attributed to the favorable reimbursement scenario and availability of advanced healthcare infrastructure. The emergence of precision medicine and personalized cancer treatment based on genetic analysis of tumor tissue over the past few decades has resulted in more specific treatment options which is further expected to influence the growth of the segment during the forecast period.
“The liquid breast biopsy segment is projected to register the highest CAGR during the forecast period.”
Based on procedure, the breast biopsy market is broadly categorized into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. The substantial growth of this segment during the review period can be attributed to the approvals and launches of new products. Companies operating in the liquid breast biopsy market are actively investing in clinical trials and research through funding and grants, which will fuel further market expansion. These initiatives by industry players are expected to drive the growth of the liquid breast biopsy segment.
“The market in the North America region is expected to witness the highest growth during the forecast period.”
The breast biopsy market in the North America region is expected to hold a major share during the forecast period, primarily due to the high healthcare spending in the region and the rising prevalence of target diseases. Moreover, continuous advancements in technology, increasing incidence rates of breast cancer, favorable reimbursement conditions, and the implementation of new breast density notification laws in the US will further boost market growth.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the breast biopsy market based on type, procedure, technique, application, end-user, and geography. This study analyses the breast biopsy market. Additionally, it discusses the elements that influence market expansion, examines the opportunities and difficulties that exist in the sector, and gives information on the market's competitive environment for market leaders. The research also examines the growth trends of micro-markets and projects the revenue of market segments for each of the five major regions (as well as the individual nations within each region).
Reasons to Buy the Report
The market leaders and new entrants will benefit from the report's information on the revenue figures that are most closely approximated for the entire breast biopsy market and its subsegments. This study will assist stakeholders in comprehending the competitive environment and gaining deeper insights to better position their companies and develop appropriate go-to-market strategies. In addition, the research provides details on the major market drivers, constraints, challenges, and opportunities, assisting stakeholders in understanding the industry's pulse.
This report provides insights on the following pointers:
“The biopsy needles sub-segment to hold the largest share of the market in 2023.”
Based on type, the breast biopsy devices market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other devices. The biopsy needles sub-segment held a major share of the market. The advantages offered by the substantial market dominance of this segment can be primarily attributed to the increasing occurrence of breast cancer and the rising rate of breast cancer diagnosis in emerging markets. Moreover, supportive government initiatives, such as the establishment of breast cancer screening programs and awareness campaigns, are anticipated to drive the adoption of breast biopsy procedures further.
“The therapy selection application segment is projected to register the highest growth during the forecast period.”
Based on application, the near breast biopsy market is broadly categorized into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The significant growth of the segment is attributed to the favorable reimbursement scenario and availability of advanced healthcare infrastructure. The emergence of precision medicine and personalized cancer treatment based on genetic analysis of tumor tissue over the past few decades has resulted in more specific treatment options which is further expected to influence the growth of the segment during the forecast period.
“The liquid breast biopsy segment is projected to register the highest CAGR during the forecast period.”
Based on procedure, the breast biopsy market is broadly categorized into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. The substantial growth of this segment during the review period can be attributed to the approvals and launches of new products. Companies operating in the liquid breast biopsy market are actively investing in clinical trials and research through funding and grants, which will fuel further market expansion. These initiatives by industry players are expected to drive the growth of the liquid breast biopsy segment.
“The market in the North America region is expected to witness the highest growth during the forecast period.”
The breast biopsy market in the North America region is expected to hold a major share during the forecast period, primarily due to the high healthcare spending in the region and the rising prevalence of target diseases. Moreover, continuous advancements in technology, increasing incidence rates of breast cancer, favorable reimbursement conditions, and the implementation of new breast density notification laws in the US will further boost market growth.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
- By Designation: C-level–10%, Director-level–14%, and Others–76%
- By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
Research Coverage
This report studies the breast biopsy market based on type, procedure, technique, application, end-user, and geography. This study analyses the breast biopsy market. Additionally, it discusses the elements that influence market expansion, examines the opportunities and difficulties that exist in the sector, and gives information on the market's competitive environment for market leaders. The research also examines the growth trends of micro-markets and projects the revenue of market segments for each of the five major regions (as well as the individual nations within each region).
Reasons to Buy the Report
The market leaders and new entrants will benefit from the report's information on the revenue figures that are most closely approximated for the entire breast biopsy market and its subsegments. This study will assist stakeholders in comprehending the competitive environment and gaining deeper insights to better position their companies and develop appropriate go-to-market strategies. In addition, the research provides details on the major market drivers, constraints, challenges, and opportunities, assisting stakeholders in understanding the industry's pulse.
This report provides insights on the following pointers:
- Analysis of key drivers (increasing incidence of breast cancer, increasing number of breast cancer screening programs, increasing demand for minimally invasive and non-invasive procedures, growing awareness regarding early detection of breast cancer, improved reimbursement scenario), restraints (risk of infections associated with the use of biopsy needles, stringent regulatory approval procedures product recalls), opportunities (emerging economies offer high growth potential, the emergence of liquid biopsy and promising clinical trials, increasing public–private investments and funding) and challenges (underdeveloped healthcare infrastructure and dearth of resources in developing countries).
- Product development/innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the breast biopsy market.
- Market development: comprehensive information about lucrative markets–the report analyses the breast biopsy market across varied regions.
- Market diversification: exhaustive information about new products, untapped geographies, recent developments, and investments in the breast biopsy market.
- Competitive assessment: in-depth assessment of market shares, growth strategies, and service offerings of leading players like Hologic Inc. (US), Becton Dickinson, and Company (US), Danaher Corporation (US), Argon Medical Devices(US), Merit Medical Systems (US), Menarini-Silicon Biosystems (ITL), Guardant Health, Inc. (US), NeoGenomics (US), Sysmex Inostics (Germany), Sterylab S.R.L ( Italy), Qiagen (Germany), and Biocept, Inc. (US).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 GLOBAL BREAST BIOPSY DEVICES MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 BREAST BIOPSY DEVICES MARKET: BREAKDOWN OF PRIMARIES
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
FIGURE 6 BREAST BIOPSY DEVICES MARKET: END-USER-BASED ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH LIMITATIONS
2.5 RISK ASSESSMENT
TABLE 1 BREAST BIOPSY DEVICES MARKET: RISK ASSESSMENT ANALYSIS
2.6 BREAST BIOPSY DEVICES MARKET: RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 8 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 9 BREAST BIOPSY DEVICES MARKET SHARE, BY PROCEDURE, 2023 VS. 2028
FIGURE 10 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 BREAST BIOPSY DEVICES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 12 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BREAST BIOPSY DEVICES MARKET
4 PREMIUM INSIGHTS
4.1 BREAST BIOPSY DEVICES MARKET OVERVIEW
FIGURE 14 INCREASING PREVALENCE OF BREAST CANCER TO DRIVE MARKET GROWTH
4.2 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 15 ASSAY KITS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 BREAST BIOPSY DEVICES MARKET, PROCEDURE, 2023 VS. 2028 (USD MILLION)
FIGURE 16 NEEDLE BREAST BIOPSY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 17 IMAGE-GUIDED BIOPSY TO ACCOUNT FOR LARGEST SHARE OF BREAST BIOPSY DEVICES MARKET IN 2028
4.5 BREAST BIOPSY DEVICES MARKET, APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 18 EARLY CANCER SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.6 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 19 BREAST CARE CENTERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.7 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028
FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 BREAST BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing incidence of breast cancer
FIGURE 22 NUMBER OF BREAST CANCER CASES, BY COUNTRY, 2020
5.2.1.2 Increasing number of breast cancer screening programs
5.2.1.3 Increasing demand for minimally invasive and non-invasive procedures
5.2.1.4 Growing awareness of early detection of breast cancer
5.2.1.5 Improved reimbursement scenario
TABLE 2 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY PROCEDURES
5.2.2 RESTRAINTS
5.2.2.1 Risk of infections associated with biopsy needles
5.2.2.2 Stringent regulatory approval procedures
5.2.2.3 Product recalls
TABLE 3 FDA-INITIATED PRODUCT RECALLS
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential in emerging economies
5.2.3.2 Emergence of liquid biopsy and promising clinical trials
TABLE 4 LIQUID BIOPSY CLINICAL TRIALS
5.2.3.3 Increasing public-private investments and funding
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals and inadequate healthcare infrastructure
5.3 REGULATORY LANDSCAPE
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.3.2 REGULATORY ANALYSIS
5.3.2.1 North America
5.3.2.1.1 US
TABLE 10 US FDA-APPROVED BIOPSY DEVICES
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.3.2.1.2 Canada
TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.3.2.2 Europe
5.3.2.3 Asia Pacific
5.3.2.3.1 Japan
TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.3.2.3.2 China
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.3.2.3.3 India
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & DEVELOPMENT
5.4.2 PROCUREMENT & PRODUCT DEVELOPMENT
5.4.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 23 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
FIGURE 24 BREAST BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
TABLE 16 BREAST BIOPSY DEVICES MARKET: ROLE IN ECOSYSTEM
5.7 TECHNOLOGY ANALYSIS
5.8 TRADE ANALYSIS
TABLE 17 IMPORT DATA FOR BIOPSY NEEDLES (HS CODE 90183240), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 18 EXPORT DATA FOR BREAST BIOPSY DEVICES (HS CODE 90183240), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 19 IMPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.9 PATENT ANALYSIS
FIGURE 25 PATENT DETAILS FOR BREAST BIOPSY (JANUARY 2012–JULY 2023)
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 21 BREAST BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE OF PRODUCTS, BY TYPE
TABLE 22 AVERAGE SELLING PRICE OF PRODUCTS (USD), 2022
5.11.2 AVERAGE SELLING PRICE TRENDS
5.12 CASE STUDY ANALYSIS
5.12.1 CASE STUDY 1: EVOLUTION OF WIRE LOCALIZATION TECHNIQUE
FIGURE 26 BREAST TUMOR LOCALIZATION: TECHNOLOGY EVOLUTION CHART
5.12.2 CASE STUDY 2: GROWING BREAST CARE FACILITIES IN US
5.13 KEY CONFERENCES & EVENTS, 2023–2025
TABLE 23 BREAST BIOPSY DEVICES MARKET: LIST OF MAJOR CONFERENCES & EVENTS (2023–2025)
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS & BUYING CRITERIA
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
5.14.2 BUYING CRITERIA
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
FIGURE 28 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
TABLE 25 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
6 BREAST BIOPSY DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 26 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 27 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2 BIOPSY NEEDLES
6.2.1 TECHNOLOGICAL ADVANCEMENTS IN BIOPSY NEEDLES TO DRIVE MARKET GROWTH
TABLE 28 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 30 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 31 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 32 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY END USER, 2021–2028 (USD MILLION)
6.3 GUIDANCE SYSTEMS
6.3.1 PROCEDURAL ADVANTAGES OF GUIDED BIOPSIES TO FUEL GROWTH
TABLE 33 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 35 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 36 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 37 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY END USER, 2021–2028 (USD MILLION)
6.4 BIOPSY TABLES
6.4.1 GROWING USE OF BIOPSY TABLES TO PERFORM STEREOTACTIC BIOPSY PROCEDURES TO FAVOR MARKET GROWTH
TABLE 38 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 40 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 41 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 42 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY END USER, 2021–2028 (USD MILLION)
6.5 ASSAY KITS
6.5.1 PRODUCT APPROVALS AND LAUNCHES TO DRIVE SEGMENTAL GROWTH
TABLE 43 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
TABLE 44 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 45 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 46 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 47 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY END USER, 2021–2028 (USD MILLION)
6.6 LIQUID BIOPSY INSTRUMENTS
6.6.1 ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET
TABLE 48 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 49 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 51 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 52 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY END USER, 2021–2028 (USD MILLION)
6.7 LOCALIZATION WIRES
6.7.1 WIDE USAGE OF LOCALIZATION WIRES TO LOCATE BREAST ABNORMALITIES AND LUMPS TO BOOST MARKET
TABLE 53 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY REGION, 2021–2028 (USD MILLION)
TABLE 54 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 56 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 57 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY END USER, 2021–2028 (USD MILLION)
6.8 OTHER DEVICES
TABLE 58 OTHER BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 59 OTHER BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 OTHER BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 61 OTHER BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 62 OTHER BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
7 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE
7.1 INTRODUCTION
TABLE 63 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
7.2 NEEDLE BREAST BIOPSY
TABLE 64 BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 CORE-NEEDLE BIOPSY
7.2.1.1 Procedural advantages of guidance system-based biopsy to drive revenue growth
TABLE 65 BREAST BIOPSY DEVICES MARKET FOR CORE-NEEDLE BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.2.2 VACUUM-ASSISTED BIOPSY
7.2.2.1 High diagnostic specificity and accuracy of technique to boost demand
TABLE 66 BREAST BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.2.3 FINE-NEEDLE ASPIRATION BIOPSY
7.2.3.1 Drawbacks associated with procedure to limit market growth
TABLE 67 BREAST BIOPSY DEVICES MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.3 OPEN SURGICAL BREAST BIOPSY
TABLE 68 BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
7.3.1 EXCISIONAL BIOPSY
7.3.1.1 Risk of postoperative complications to hinder market growth
TABLE 69 BREAST BIOPSY DEVICES MARKET FOR EXCISIONAL BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.3.2 INCISIONAL BIOPSY
7.3.2.1 Longer recovery period associated with incisional biopsy to restrict growth
TABLE 70 BREAST BIOPSY DEVICES MARKET FOR INCISIONAL BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.4 LIQUID BREAST BIOPSY
TABLE 71 BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
7.4.1 CIRCULATING TUMOR CELLS
7.4.1.1 Ability to provide important information on molecular properties of breast tumors to boost market
TABLE 72 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2021–2028 (USD MILLION)
7.4.2 CIRCULATING TUMOR DNA
7.4.2.1 Low concentrations of ctDNA to pose challenges in screening mutations
TABLE 73 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2021–2028 (USD MILLION)
7.4.3 OTHER BIOMARKERS
TABLE 74 BREAST BIOPSY DEVICES MARKET FOR OTHER BIOMARKERS, BY REGION, 2021–2028 (USD MILLION)
8 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE
8.1 INTRODUCTION
TABLE 75 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
8.2 IMAGE-GUIDED BIOPSY
TABLE 76 BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
8.2.1 MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
8.2.1.1 Increasing number of government-initiated breast screening programs to drive segmental growth
TABLE 77 BREAST BIOPSY DEVICES MARKET FOR MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.2.2 ULTRASOUND-GUIDED BIOPSY
8.2.2.1 Advantages of technique to boost adoption in coming years
TABLE 78 BREAST BIOPSY DEVICES MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.2.3 MRI-GUIDED BIOPSY
8.2.3.1 High cost and low specificity to affect demand
TABLE 79 BREAST BIOPSY DEVICES MARKET FOR MRI-GUIDED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.3 LIQUID BIOPSY
TABLE 80 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
8.3.1 PCR-BASED BIOPSY
8.3.1.1 Continuous advancements in PCR technology to propel growth
TABLE 81 BREAST BIOPSY DEVICES MARKET FOR PCR-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.3.2 NGS-BASED BIOPSY
8.3.2.1 Technological advancements and advantages to drive growth
TABLE 82 NGS-BASED TECHNOLOGIES FOR ONCOLOGY APPLICATIONS
TABLE 83 BREAST BIOPSY DEVICES MARKET FOR NGS-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.3.3 MICROARRAY-BASED BIOPSY
8.3.3.1 Ongoing research and promising results to drive market growth
TABLE 84 BREAST BIOPSY DEVICES MARKET FOR MICROARRAY-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.4 OTHER TECHNIQUES
TABLE 85 BREAST BIOPSY DEVICES MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION)
9 BREAST BIOPSY DEVICES MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 86 BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 EARLY CANCER SCREENING
9.2.1 GROWING AWARENESS ABOUT EARLY CANCER DETECTION TO DRIVE MARKET GROWTH
TABLE 87 BREAST BIOPSY DEVICES MARKET FOR EARLY CANCER SCREENING, BY REGION, 2021–2028 (USD MILLION)
9.3 THERAPY SELECTION
9.3.1 EMERGENCE OF PLASMA-BASED GENOTYPING TO DRIVE GROWTH IN DEVELOPED COUNTRIES
TABLE 88 BREAST BIOPSY DEVICES MARKET FOR THERAPY SELECTION, BY REGION, 2021–2028 (USD MILLION)
9.4 TREATMENT MONITORING
9.4.1 GROWING DEMAND FOR LIQUID BIOPSY FOR REAL-TIME TREATMENT MONITORING TO BOOST MARKET
TABLE 89 BREAST BIOPSY DEVICES MARKET FOR TREATMENT MONITORING, BY REGION, 2021–2028 (USD MILLION)
9.5 RECURRENCE MONITORING
9.5.1 UNMET CLINICAL NEEDS TO CREATE OPPORTUNITIES FOR PLAYERS
TABLE 90 BREAST BIOPSY DEVICES MARKET FOR RECURRENCE MONITORING, BY REGION, 2021–2028 (USD MILLION)
10 BREAST BIOPSY DEVICES MARKET, BY END USER
10.1 INTRODUCTION
TABLE 91 BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 HOSPITALS & SURGICAL CENTERS
10.2.1 RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST MARKET
TABLE 92 BREAST BIOPSY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION)
10.3 BREAST CARE CENTERS
10.3.1 GROWING POPULARITY OF BREAST CARE CENTERS IN DEVELOPED COUNTRIES TO FUEL GROWTH
TABLE 93 BREAST BIOPSY DEVICES MARKET FOR BREAST CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
10.4 IMAGING CLINICS & DIAGNOSTIC CENTERS
10.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS TO CONTRIBUTE TO MARKET GROWTH
TABLE 94 BREAST BIOPSY DEVICES MARKET FOR IMAGING CLINICS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
11 BREAST BIOPSY DEVICES MARKET, BY REGION
11.1 INTRODUCTION
TABLE 95 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET SNAPSHOT
11.2.1 NORTH AMERICA: RECESSION IMPACT
TABLE 96 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 101 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.2 US
11.2.2.1 US to dominate North American breast biopsy devices market during forecast period
TABLE 107 US: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Growing incidence of breast cancer and favorable government guidelines to support market growth
TABLE 108 CANADA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
TABLE 109 EUROPE: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 EUROPE: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 112 EUROPE: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 EUROPE: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 EUROPE: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Favorable changes in reimbursement scenario to fuel adoption of technologically advanced products
TABLE 120 GERMANY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.3 UK
11.3.3.1 Initiatives by public & private organizations to increase awareness about breast cancer
TABLE 121 UK: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Rising geriatric population to support market growth
TABLE 122 FRANCE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Evolving regulatory scenario for breast biopsy to boost market
TABLE 123 ITALY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Government focus on early and effective breast cancer diagnosis to favor market growth
TABLE 124 SPAIN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 125 REST OF EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET SNAPSHOT
11.4.1 ASIA PACIFIC: RECESSION IMPACT
TABLE 126 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 133 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 134 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Increasing patient pool and government initiatives for healthcare development to fuel market growth
TABLE 137 CHINA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.3 JAPAN
11.4.3.1 Presence of universal healthcare reimbursement scenario to support growth
TABLE 138 JAPAN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Government initiatives to improve female health to drive market growth in India
TABLE 139 INDIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.5 AUSTRALIA
11.4.5.1 Rising research investments and awareness campaigns to fuel growth
TABLE 140 AUSTRALIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.6 SOUTH KOREA
11.4.6.1 Rising R&D and promising clinical trials to positively impact market growth
TABLE 141 SOUTH KOREA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 142 REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 143 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 146 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 150 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 151 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Brazil to dominate Latin American market during forecast period
TABLE 154 BRAZIL: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 Availability of advanced care and increasing awareness programs to fuel market growth
TABLE 155 MEXICO: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 156 REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5.5 MIDDLE EAST & AFRICA
11.5.5.1 Improving healthcare infrastructure and increasing public-private investments to drive market
11.5.6 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 157 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 159 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 163 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
FIGURE 31 KEY DEVELOPMENTS BY LEADING PLAYERS IN BREAST BIOPSY DEVICES MARKET, JANUARY 2020–FEBRUARY 2022
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE SHARE ANALYSIS
FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS
12.4 MARKET SHARE ANALYSIS
FIGURE 33 BREAST BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER (2022)
12.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 34 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (2022)
12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 35 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
12.7 COMPETITIVE BENCHMARKING
TABLE 167 BREAST BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING
12.8 COMPANY FOOTPRINT ANALYSIS
TABLE 168 BREAST BIOPSY DEVICES MARKET: REGIONAL FOOTPRINT ANALYSIS
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
13 COMPANY PROFILES
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 HOLOGIC, INC.
TABLE 169 HOLOGIC, INC.: BUSINESS OVERVIEW
FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
TABLE 170 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 171 HOLOGIC, INC.: DEALS
13.1.2 DANAHER CORPORATION
TABLE 172 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 173 DANAHER CORPORATION: PRODUCT LAUNCHES
13.1.3 BECTON, DICKINSON AND COMPANY
TABLE 174 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
TABLE 175 BECTON, DICKINSON AND COMPANY: EXPANSIONS
13.1.4 QIAGEN
TABLE 176 QIAGEN: BUSINESS OVERVIEW
FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
TABLE 177 QIAGEN: PRODUCT LAUNCHES
13.1.5 F. HOFFMANN-LA ROCHE LTD.
TABLE 178 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
13.1.6 ARGON MEDICAL DEVICES
TABLE 179 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
TABLE 180 ARGON MEDICAL DEVICES: PRODUCT LAUNCHES
TABLE 181 ARGON MEDICAL DEVICES: DEALS
13.1.7 MERIT MEDICAL SYSTEMS
TABLE 182 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2022)
TABLE 183 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS
TABLE 184 MERIT MEDICAL SYSTEMS: DEALS
13.1.8 MENARINI SILICON BIOSYSTEMS SPA
TABLE 185 MENARINI SILICON BIOSYSTEMS: BUSINESS OVERVIEW
TABLE 186 MENARINI SILICON BIOSYSTEMS: PRODUCT LAUNCHES
TABLE 187 MENARINI SILICON BIOSYSTEMS: DEALS
13.1.9 GUARDANT HEALTH, INC.
TABLE 188 GUARDANT HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 42 GUARDANT HEALTH, INC.: COMPANY SNAPSHOT (2022)
TABLE 189 GUARDANT HEALTH, INC.: DEALS
13.1.10 NEOGENOMICS LABORATORIES, INC.
TABLE 190 NEOGENOMICS LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 43 NEOGENOMICS LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 191 NEOGENOMICS LABORATORIES, INC.: PRODUCT LAUNCHES
TABLE 192 NEOGENOMICS LABORATORIES, INC.: DEALS
13.1.11 STERYLAB S.R.L
TABLE 193 STERYLAB S.R.L: BUSINESS OVERVIEW
13.1.12 BIOCEPT, INC.
TABLE 194 BIOCEPT, INC.: BUSINESS OVERVIEW
13.1.13 BIO-RAD LABORATORIES, INC.
TABLE 195 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
13.1.14 EXACT SCIENCES CORPORATION
TABLE 196 EXACT SCIENCES CORPORATION: BUSINESS OVERVIEW
FIGURE 45 EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 197 EXACT SCIENCES CORPORATION: DEALS
13.1.15 SYSMEX INOSTICS, INC. (A SUBSIDIARY OF SYSMEX CORPORATION)
TABLE 198 SYSMEX INOSTICS: BUSINESS OVERVIEW
FIGURE 46 SYSMEX INOSTICS: COMPANY SNAPSHOT (2022)
TABLE 199 SYSMEX INOSTICS: DEALS
13.2 OTHER PLAYERS
13.2.1 THERMO FISHER SCIENTIFIC
13.2.2 CARDIFF ONCOLOGY INC.
13.2.3 MYRIAD GENETICS, INC.
13.2.4 ILLUMINA, INC.
13.2.5 FLUXION BIOSCIENCES, INC.
13.2.6 FUJIFILM HOLDINGS CORPORATION
13.2.7 INRAD, INC.
13.2.8 IZI MEDICAL PRODUCTS
13.2.9 REMINGTON MEDICAL INC.
13.2.10 CP MEDICAL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.5.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 GLOBAL BREAST BIOPSY DEVICES MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 BREAST BIOPSY DEVICES MARKET: BREAKDOWN OF PRIMARIES
2.1.2.1 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
FIGURE 6 BREAST BIOPSY DEVICES MARKET: END-USER-BASED ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH LIMITATIONS
2.5 RISK ASSESSMENT
TABLE 1 BREAST BIOPSY DEVICES MARKET: RISK ASSESSMENT ANALYSIS
2.6 BREAST BIOPSY DEVICES MARKET: RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 8 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 9 BREAST BIOPSY DEVICES MARKET SHARE, BY PROCEDURE, 2023 VS. 2028
FIGURE 10 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 BREAST BIOPSY DEVICES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
FIGURE 12 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BREAST BIOPSY DEVICES MARKET
4 PREMIUM INSIGHTS
4.1 BREAST BIOPSY DEVICES MARKET OVERVIEW
FIGURE 14 INCREASING PREVALENCE OF BREAST CANCER TO DRIVE MARKET GROWTH
4.2 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 15 ASSAY KITS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.3 BREAST BIOPSY DEVICES MARKET, PROCEDURE, 2023 VS. 2028 (USD MILLION)
FIGURE 16 NEEDLE BREAST BIOPSY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
FIGURE 17 IMAGE-GUIDED BIOPSY TO ACCOUNT FOR LARGEST SHARE OF BREAST BIOPSY DEVICES MARKET IN 2028
4.5 BREAST BIOPSY DEVICES MARKET, APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 18 EARLY CANCER SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.6 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 19 BREAST CARE CENTERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.7 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028
FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 BREAST BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing incidence of breast cancer
FIGURE 22 NUMBER OF BREAST CANCER CASES, BY COUNTRY, 2020
5.2.1.2 Increasing number of breast cancer screening programs
5.2.1.3 Increasing demand for minimally invasive and non-invasive procedures
5.2.1.4 Growing awareness of early detection of breast cancer
5.2.1.5 Improved reimbursement scenario
TABLE 2 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY PROCEDURES
5.2.2 RESTRAINTS
5.2.2.1 Risk of infections associated with biopsy needles
5.2.2.2 Stringent regulatory approval procedures
5.2.2.3 Product recalls
TABLE 3 FDA-INITIATED PRODUCT RECALLS
5.2.3 OPPORTUNITIES
5.2.3.1 Growth potential in emerging economies
5.2.3.2 Emergence of liquid biopsy and promising clinical trials
TABLE 4 LIQUID BIOPSY CLINICAL TRIALS
5.2.3.3 Increasing public-private investments and funding
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals and inadequate healthcare infrastructure
5.3 REGULATORY LANDSCAPE
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.3.2 REGULATORY ANALYSIS
5.3.2.1 North America
5.3.2.1.1 US
TABLE 10 US FDA-APPROVED BIOPSY DEVICES
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.3.2.1.2 Canada
TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.3.2.2 Europe
5.3.2.3 Asia Pacific
5.3.2.3.1 Japan
TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.3.2.3.2 China
TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.3.2.3.3 India
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & DEVELOPMENT
5.4.2 PROCUREMENT & PRODUCT DEVELOPMENT
5.4.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 23 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
FIGURE 24 BREAST BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM MARKET MAP
TABLE 16 BREAST BIOPSY DEVICES MARKET: ROLE IN ECOSYSTEM
5.7 TECHNOLOGY ANALYSIS
5.8 TRADE ANALYSIS
TABLE 17 IMPORT DATA FOR BIOPSY NEEDLES (HS CODE 90183240), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 18 EXPORT DATA FOR BREAST BIOPSY DEVICES (HS CODE 90183240), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 19 IMPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018–2022 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.9 PATENT ANALYSIS
FIGURE 25 PATENT DETAILS FOR BREAST BIOPSY (JANUARY 2012–JULY 2023)
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 21 BREAST BIOPSY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICE OF PRODUCTS, BY TYPE
TABLE 22 AVERAGE SELLING PRICE OF PRODUCTS (USD), 2022
5.11.2 AVERAGE SELLING PRICE TRENDS
5.12 CASE STUDY ANALYSIS
5.12.1 CASE STUDY 1: EVOLUTION OF WIRE LOCALIZATION TECHNIQUE
FIGURE 26 BREAST TUMOR LOCALIZATION: TECHNOLOGY EVOLUTION CHART
5.12.2 CASE STUDY 2: GROWING BREAST CARE FACILITIES IN US
5.13 KEY CONFERENCES & EVENTS, 2023–2025
TABLE 23 BREAST BIOPSY DEVICES MARKET: LIST OF MAJOR CONFERENCES & EVENTS (2023–2025)
5.14 KEY STAKEHOLDERS & BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS & BUYING CRITERIA
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
5.14.2 BUYING CRITERIA
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
FIGURE 28 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
TABLE 25 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
6 BREAST BIOPSY DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 26 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 27 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2 BIOPSY NEEDLES
6.2.1 TECHNOLOGICAL ADVANCEMENTS IN BIOPSY NEEDLES TO DRIVE MARKET GROWTH
TABLE 28 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 30 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 31 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 32 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY END USER, 2021–2028 (USD MILLION)
6.3 GUIDANCE SYSTEMS
6.3.1 PROCEDURAL ADVANTAGES OF GUIDED BIOPSIES TO FUEL GROWTH
TABLE 33 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 35 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 36 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 37 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY END USER, 2021–2028 (USD MILLION)
6.4 BIOPSY TABLES
6.4.1 GROWING USE OF BIOPSY TABLES TO PERFORM STEREOTACTIC BIOPSY PROCEDURES TO FAVOR MARKET GROWTH
TABLE 38 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY REGION, 2021–2028 (USD MILLION)
TABLE 39 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 40 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 41 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 42 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY END USER, 2021–2028 (USD MILLION)
6.5 ASSAY KITS
6.5.1 PRODUCT APPROVALS AND LAUNCHES TO DRIVE SEGMENTAL GROWTH
TABLE 43 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)
TABLE 44 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 45 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 46 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 47 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY END USER, 2021–2028 (USD MILLION)
6.6 LIQUID BIOPSY INSTRUMENTS
6.6.1 ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET
TABLE 48 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 49 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 51 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 52 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY END USER, 2021–2028 (USD MILLION)
6.7 LOCALIZATION WIRES
6.7.1 WIDE USAGE OF LOCALIZATION WIRES TO LOCATE BREAST ABNORMALITIES AND LUMPS TO BOOST MARKET
TABLE 53 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY REGION, 2021–2028 (USD MILLION)
TABLE 54 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 56 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 57 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY END USER, 2021–2028 (USD MILLION)
6.8 OTHER DEVICES
TABLE 58 OTHER BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 59 OTHER BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 OTHER BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 61 OTHER BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 62 OTHER BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
7 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE
7.1 INTRODUCTION
TABLE 63 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
7.2 NEEDLE BREAST BIOPSY
TABLE 64 BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
7.2.1 CORE-NEEDLE BIOPSY
7.2.1.1 Procedural advantages of guidance system-based biopsy to drive revenue growth
TABLE 65 BREAST BIOPSY DEVICES MARKET FOR CORE-NEEDLE BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.2.2 VACUUM-ASSISTED BIOPSY
7.2.2.1 High diagnostic specificity and accuracy of technique to boost demand
TABLE 66 BREAST BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.2.3 FINE-NEEDLE ASPIRATION BIOPSY
7.2.3.1 Drawbacks associated with procedure to limit market growth
TABLE 67 BREAST BIOPSY DEVICES MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.3 OPEN SURGICAL BREAST BIOPSY
TABLE 68 BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
7.3.1 EXCISIONAL BIOPSY
7.3.1.1 Risk of postoperative complications to hinder market growth
TABLE 69 BREAST BIOPSY DEVICES MARKET FOR EXCISIONAL BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.3.2 INCISIONAL BIOPSY
7.3.2.1 Longer recovery period associated with incisional biopsy to restrict growth
TABLE 70 BREAST BIOPSY DEVICES MARKET FOR INCISIONAL BIOPSY, BY REGION, 2021–2028 (USD MILLION)
7.4 LIQUID BREAST BIOPSY
TABLE 71 BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
7.4.1 CIRCULATING TUMOR CELLS
7.4.1.1 Ability to provide important information on molecular properties of breast tumors to boost market
TABLE 72 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2021–2028 (USD MILLION)
7.4.2 CIRCULATING TUMOR DNA
7.4.2.1 Low concentrations of ctDNA to pose challenges in screening mutations
TABLE 73 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2021–2028 (USD MILLION)
7.4.3 OTHER BIOMARKERS
TABLE 74 BREAST BIOPSY DEVICES MARKET FOR OTHER BIOMARKERS, BY REGION, 2021–2028 (USD MILLION)
8 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE
8.1 INTRODUCTION
TABLE 75 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
8.2 IMAGE-GUIDED BIOPSY
TABLE 76 BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
8.2.1 MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
8.2.1.1 Increasing number of government-initiated breast screening programs to drive segmental growth
TABLE 77 BREAST BIOPSY DEVICES MARKET FOR MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.2.2 ULTRASOUND-GUIDED BIOPSY
8.2.2.1 Advantages of technique to boost adoption in coming years
TABLE 78 BREAST BIOPSY DEVICES MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.2.3 MRI-GUIDED BIOPSY
8.2.3.1 High cost and low specificity to affect demand
TABLE 79 BREAST BIOPSY DEVICES MARKET FOR MRI-GUIDED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.3 LIQUID BIOPSY
TABLE 80 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
8.3.1 PCR-BASED BIOPSY
8.3.1.1 Continuous advancements in PCR technology to propel growth
TABLE 81 BREAST BIOPSY DEVICES MARKET FOR PCR-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.3.2 NGS-BASED BIOPSY
8.3.2.1 Technological advancements and advantages to drive growth
TABLE 82 NGS-BASED TECHNOLOGIES FOR ONCOLOGY APPLICATIONS
TABLE 83 BREAST BIOPSY DEVICES MARKET FOR NGS-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.3.3 MICROARRAY-BASED BIOPSY
8.3.3.1 Ongoing research and promising results to drive market growth
TABLE 84 BREAST BIOPSY DEVICES MARKET FOR MICROARRAY-BASED BIOPSY, BY REGION, 2021–2028 (USD MILLION)
8.4 OTHER TECHNIQUES
TABLE 85 BREAST BIOPSY DEVICES MARKET FOR OTHER TECHNIQUES, BY REGION, 2021–2028 (USD MILLION)
9 BREAST BIOPSY DEVICES MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 86 BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
9.2 EARLY CANCER SCREENING
9.2.1 GROWING AWARENESS ABOUT EARLY CANCER DETECTION TO DRIVE MARKET GROWTH
TABLE 87 BREAST BIOPSY DEVICES MARKET FOR EARLY CANCER SCREENING, BY REGION, 2021–2028 (USD MILLION)
9.3 THERAPY SELECTION
9.3.1 EMERGENCE OF PLASMA-BASED GENOTYPING TO DRIVE GROWTH IN DEVELOPED COUNTRIES
TABLE 88 BREAST BIOPSY DEVICES MARKET FOR THERAPY SELECTION, BY REGION, 2021–2028 (USD MILLION)
9.4 TREATMENT MONITORING
9.4.1 GROWING DEMAND FOR LIQUID BIOPSY FOR REAL-TIME TREATMENT MONITORING TO BOOST MARKET
TABLE 89 BREAST BIOPSY DEVICES MARKET FOR TREATMENT MONITORING, BY REGION, 2021–2028 (USD MILLION)
9.5 RECURRENCE MONITORING
9.5.1 UNMET CLINICAL NEEDS TO CREATE OPPORTUNITIES FOR PLAYERS
TABLE 90 BREAST BIOPSY DEVICES MARKET FOR RECURRENCE MONITORING, BY REGION, 2021–2028 (USD MILLION)
10 BREAST BIOPSY DEVICES MARKET, BY END USER
10.1 INTRODUCTION
TABLE 91 BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 HOSPITALS & SURGICAL CENTERS
10.2.1 RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST MARKET
TABLE 92 BREAST BIOPSY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021–2028 (USD MILLION)
10.3 BREAST CARE CENTERS
10.3.1 GROWING POPULARITY OF BREAST CARE CENTERS IN DEVELOPED COUNTRIES TO FUEL GROWTH
TABLE 93 BREAST BIOPSY DEVICES MARKET FOR BREAST CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
10.4 IMAGING CLINICS & DIAGNOSTIC CENTERS
10.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS TO CONTRIBUTE TO MARKET GROWTH
TABLE 94 BREAST BIOPSY DEVICES MARKET FOR IMAGING CLINICS & DIAGNOSTIC CENTERS, BY REGION, 2021–2028 (USD MILLION)
11 BREAST BIOPSY DEVICES MARKET, BY REGION
11.1 INTRODUCTION
TABLE 95 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 29 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET SNAPSHOT
11.2.1 NORTH AMERICA: RECESSION IMPACT
TABLE 96 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 100 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 101 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 103 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 104 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2.2 US
11.2.2.1 US to dominate North American breast biopsy devices market during forecast period
TABLE 107 US: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Growing incidence of breast cancer and favorable government guidelines to support market growth
TABLE 108 CANADA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
TABLE 109 EUROPE: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 110 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 EUROPE: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 112 EUROPE: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 EUROPE: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 EUROPE: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Favorable changes in reimbursement scenario to fuel adoption of technologically advanced products
TABLE 120 GERMANY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.3 UK
11.3.3.1 Initiatives by public & private organizations to increase awareness about breast cancer
TABLE 121 UK: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Rising geriatric population to support market growth
TABLE 122 FRANCE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Evolving regulatory scenario for breast biopsy to boost market
TABLE 123 ITALY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Government focus on early and effective breast cancer diagnosis to favor market growth
TABLE 124 SPAIN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 125 REST OF EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET SNAPSHOT
11.4.1 ASIA PACIFIC: RECESSION IMPACT
TABLE 126 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 127 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 129 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 133 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 134 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 135 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Increasing patient pool and government initiatives for healthcare development to fuel market growth
TABLE 137 CHINA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.3 JAPAN
11.4.3.1 Presence of universal healthcare reimbursement scenario to support growth
TABLE 138 JAPAN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Government initiatives to improve female health to drive market growth in India
TABLE 139 INDIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.5 AUSTRALIA
11.4.5.1 Rising research investments and awareness campaigns to fuel growth
TABLE 140 AUSTRALIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.6 SOUTH KOREA
11.4.6.1 Rising R&D and promising clinical trials to positively impact market growth
TABLE 141 SOUTH KOREA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 142 REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 143 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 144 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 146 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 149 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 150 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 151 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Brazil to dominate Latin American market during forecast period
TABLE 154 BRAZIL: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 Availability of advanced care and increasing awareness programs to fuel market growth
TABLE 155 MEXICO: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 156 REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
11.5.5 MIDDLE EAST & AFRICA
11.5.5.1 Improving healthcare infrastructure and increasing public-private investments to drive market
11.5.6 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 157 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 158 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
TABLE 159 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 163 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
TABLE 164 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 165 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021–2028 (USD MILLION)
TABLE 166 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
FIGURE 31 KEY DEVELOPMENTS BY LEADING PLAYERS IN BREAST BIOPSY DEVICES MARKET, JANUARY 2020–FEBRUARY 2022
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE SHARE ANALYSIS
FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS
12.4 MARKET SHARE ANALYSIS
FIGURE 33 BREAST BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER (2022)
12.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 34 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (2022)
12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 35 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
12.7 COMPETITIVE BENCHMARKING
TABLE 167 BREAST BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING
12.8 COMPANY FOOTPRINT ANALYSIS
TABLE 168 BREAST BIOPSY DEVICES MARKET: REGIONAL FOOTPRINT ANALYSIS
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
13 COMPANY PROFILES
13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 HOLOGIC, INC.
TABLE 169 HOLOGIC, INC.: BUSINESS OVERVIEW
FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
TABLE 170 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 171 HOLOGIC, INC.: DEALS
13.1.2 DANAHER CORPORATION
TABLE 172 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 173 DANAHER CORPORATION: PRODUCT LAUNCHES
13.1.3 BECTON, DICKINSON AND COMPANY
TABLE 174 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
TABLE 175 BECTON, DICKINSON AND COMPANY: EXPANSIONS
13.1.4 QIAGEN
TABLE 176 QIAGEN: BUSINESS OVERVIEW
FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
TABLE 177 QIAGEN: PRODUCT LAUNCHES
13.1.5 F. HOFFMANN-LA ROCHE LTD.
TABLE 178 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
13.1.6 ARGON MEDICAL DEVICES
TABLE 179 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
TABLE 180 ARGON MEDICAL DEVICES: PRODUCT LAUNCHES
TABLE 181 ARGON MEDICAL DEVICES: DEALS
13.1.7 MERIT MEDICAL SYSTEMS
TABLE 182 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2022)
TABLE 183 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS
TABLE 184 MERIT MEDICAL SYSTEMS: DEALS
13.1.8 MENARINI SILICON BIOSYSTEMS SPA
TABLE 185 MENARINI SILICON BIOSYSTEMS: BUSINESS OVERVIEW
TABLE 186 MENARINI SILICON BIOSYSTEMS: PRODUCT LAUNCHES
TABLE 187 MENARINI SILICON BIOSYSTEMS: DEALS
13.1.9 GUARDANT HEALTH, INC.
TABLE 188 GUARDANT HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 42 GUARDANT HEALTH, INC.: COMPANY SNAPSHOT (2022)
TABLE 189 GUARDANT HEALTH, INC.: DEALS
13.1.10 NEOGENOMICS LABORATORIES, INC.
TABLE 190 NEOGENOMICS LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 43 NEOGENOMICS LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
TABLE 191 NEOGENOMICS LABORATORIES, INC.: PRODUCT LAUNCHES
TABLE 192 NEOGENOMICS LABORATORIES, INC.: DEALS
13.1.11 STERYLAB S.R.L
TABLE 193 STERYLAB S.R.L: BUSINESS OVERVIEW
13.1.12 BIOCEPT, INC.
TABLE 194 BIOCEPT, INC.: BUSINESS OVERVIEW
13.1.13 BIO-RAD LABORATORIES, INC.
TABLE 195 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
13.1.14 EXACT SCIENCES CORPORATION
TABLE 196 EXACT SCIENCES CORPORATION: BUSINESS OVERVIEW
FIGURE 45 EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 197 EXACT SCIENCES CORPORATION: DEALS
13.1.15 SYSMEX INOSTICS, INC. (A SUBSIDIARY OF SYSMEX CORPORATION)
TABLE 198 SYSMEX INOSTICS: BUSINESS OVERVIEW
FIGURE 46 SYSMEX INOSTICS: COMPANY SNAPSHOT (2022)
TABLE 199 SYSMEX INOSTICS: DEALS
13.2 OTHER PLAYERS
13.2.1 THERMO FISHER SCIENTIFIC
13.2.2 CARDIFF ONCOLOGY INC.
13.2.3 MYRIAD GENETICS, INC.
13.2.4 ILLUMINA, INC.
13.2.5 FLUXION BIOSCIENCES, INC.
13.2.6 FUJIFILM HOLDINGS CORPORATION
13.2.7 INRAD, INC.
13.2.8 IZI MEDICAL PRODUCTS
13.2.9 REMINGTON MEDICAL INC.
13.2.10 CP MEDICAL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
